JDOCvsPPH
JPMorgan Healthcare Leaders ETF against VanEck Pharmaceutical ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| JDOC | PPH | |
|---|---|---|
| Expense ratio | 0.65% | 0.36% |
| Assets | $9048.54T | $1B |
| Net flow, 1 month | — | +$44M |
| Net flow, 1 year | −$25K | +$325M |
| Return, YTD | +2.9% | +4.7% |
| Return, 1 year | +10.6% | +15.8% |
| Avg daily volume | 241 | 286K |
| Holdings | 67 | 27 |
| Listed | Oct 31, 2023 | Feb 1, 2000 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS